Research & Development



  春風早,看東南王氣,飛繞星躔。”   “料理戰事吧!我去睡了。午時繼續出發!”自色拍去偷拍亚洲免费   “傻子啊,你師傅不可能一直留在張掖,要殺,也是陛下的事情,是張掖郡郡守的事情。大漢國有蕭規曹隨的習慣,我們立下規矩,後來的官員跟著施行就是了。”色婷婷亚洲婷婷7月   羊盤上一旦開始著火,就很難熄滅,破壞羊盤對匈奴牧人來說就是在破壞他們的城池。   雲瑯自然是不同的,夜晚的時候抱著甦稚嬌嫩的身體,不管看多久,都百看不厭。欧美亚洲色综合图区19p   這樣的事情也絕對不該是司馬相如這個層次的官員能知道的。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo